SCHEMBL2814404

SCHEMBL2814404

COc1ccc(CN2CCc3nn(Cc4ccccc4)c4nc(N5CCN(C)CC5)nc2c34)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HRH4 Q9H3N8 6/20 0.44
HRH1 P35367 4/20 0.44
HTR6 P50406 1/20 0.42
USP2 O75604 7/20 0.42
CYP3A4 P08684 6/20 0.42
ALDH1A1 P00352 8/20 0.41
GLA P06280 4/20 0.41
CASP1 P29466 4/20 0.41
CASP7 P55210 4/20 0.41
HIF1A Q16665 4/20 0.41
CYP2D6 P10635 2/20 0.41
MEN1 O00255 2/20 0.41
KMT2A Q03164 2/20 0.41
HBB P68871 1/20 0.41
HSD17B10 Q99714 1/20 0.41
CYP1A2 P05177 3/20 0.41
TSHR P16473 2/20 0.41
CYP2C19 P33261 2/20 0.40
LMNA P02545 3/20 0.40
MAPK1 P28482 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2809473 0.93 TSHR (0.42) ALDH1A1MEN1KMT2AHSD17B10TSHR
SCHEMBL2811750 0.92 HTT (0.47) ALDH1A1CASP1MEN1KMT2ATSHR
SCHEMBL2808405 0.90 CFTR (0.49) USP2ALDH1A1MEN1KMT2AHSD17B10
SCHEMBL538222 0.90 ALDH1A1 (0.42) USP2CYP3A4ALDH1A1CASP1CASP7
SCHEMBL2814817 0.89 KDM4E (0.42) ALDH1A1CASP1MEN1KMT2ACYP1A2
SCHEMBL2808261 0.89 TSHR (0.45) ALDH1A1MEN1KMT2ATSHRLMNA
SCHEMBL2809514 0.88 HTR6 (0.46) HRH4HRH1HTR6USP2CYP3A4
SCHEMBL2809524 0.86 ADORA2A (0.40) USP2CYP3A4ALDH1A1MEN1KMT2A
SCHEMBL2809932 0.84 ALDH1A1 (0.42) ALDH1A1MEN1KMT2ATSHRLMNA
SCHEMBL2812071 0.84 SMN1; SMN2 (0.43) ALDH1A1KMT2AHSD17B10TSHRLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8343983-B2 Substituted pyrazolo-pyrimidine compounds ARQULE, INC. (US) 2013-01-01 US disclosed
US-8343983-B2 Substituted pyrazolo-pyrimidine compounds ARQULE, INC. (US) 2013-01-01 US disclosed
US-8343983-B2 Substituted pyrazolo-pyrimidine compounds ARQULE, INC. (US) 2013-01-01 US disclosed
WO-2010114905-A1 PERI-FUSED PYRAZOLO-PYRIMIDINE COMPOUNDS ARQULE, INC. (US) 2010-10-07 WO disclosed
US-20100249110-A1 SUBSTITUTED PYRAZOLO-PYRIMIDINE COMPOUNDS ARQULE, INC. (US) 2010-09-30 US disclosed
US-20100249110-A1 SUBSTITUTED PYRAZOLO-PYRIMIDINE COMPOUNDS ARQULE, INC. (US) 2010-09-30 US disclosed
US-20100249110-A1 SUBSTITUTED PYRAZOLO-PYRIMIDINE COMPOUNDS ARQULE, INC. (US) 2010-09-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100249110-A1 SUBSTITUTED PYRAZOLO-PYRIMIDINE COMPOUNDS DPYD, TYMP, TP53 HRH4 1891/4885HRH1 2327/4885HTR6 1986/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.